Biotech | March 22, 2022
Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
The company plans to launch the product immediately
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
Sputnik Light is the first component of Sputnik V
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
Subscribe To Our Newsletter & Stay Updated
